Treatment of IgG4-Related Disease With Revlimid and Rituximab

NCT02705638 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

6

Enrollment

OTHER

Sponsor class

Conditions

Immunoglobulin G Subclass 4 Related Disease
IgG4-related Disease
Autoimmune Pancreatitis
IgG4-related Sclerosing Cholangitis
Retroperitoneal Fibrosis

Interventions

DRUG: Rituximab
DRUG: Lenalidomide

Sponsor

Mayo Clinic

Collaborators

[object Object]